v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Series A Convertible
Preferred Stock
Series B Convertible
Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Receivable Related to Employee Equity Awards
Total
Balance at Dec. 31, 2024 $ 53 $ 105,998,412 $ (103,438,099)   $ 2,560,366
Balance (in Shares) at Dec. 31, 2024 17.488 536,908        
Common stock issued for cash $ 21 1,003,197   1,003,218
Common stock issued for cash (in Shares)     215,482        
Fair value of vested stock options 132,279   132,279
Fair value of vested restricted stock units     39,530   39,530
Net loss (2,262,242)   (2,262,242)
Balance at Jun. 30, 2025 $ 74 107,173,418 (105,700,341)   1,473,151
Balance (in Shares) at Jun. 30, 2025 17.488 752,390        
Balance at Mar. 31, 2025 $ 55 106,227,259 (104,474,429)   1,752,885
Balance (in Shares) at Mar. 31, 2025 17.488   562,213        
Common stock issued for cash $ 19 857,396   857,415
Common stock issued for cash (in Shares)     190,177        
Fair value of vested stock options 49,233   49,233
Fair value of vested restricted stock units 39,530   39,530
Net loss (1,225,912)   (1,225,912)
Balance at Jun. 30, 2025 $ 74 107,173,418 (105,700,341)   1,473,151
Balance (in Shares) at Jun. 30, 2025 17.488 752,390        
Balance at Dec. 31, 2025 $ 116 112,725,513 (110,465,509) 2,260,120
Balance (in Shares) at Dec. 31, 2025 17.488 1,176,477        
Common stock issued for cash $ 8 357,676 357,684
Common stock issued for cash (in Shares)     82,174        
Common stock issued for cash - private fundraising     $ 6 158,007     158,013
Common stock issued for cash - private fundraising (in Shares)     66,846        
Fair value allocated to warrants during fundraising       2,432,783 2,432,783
Fair value allocated to prefunded warrants during fundraising       1,209,206 1,209,206
Fair value of vested stock options 8,292 8,292
Fair value of vested restricted stock awards     $ 3 101,172 101,175
Fair value of vested restricted stock awards (in Shares)     29,326        
Fair value of vested restricted stock units $ 15 1,006,873 (72,981) 933,907
Fair value of vested restricted stock units (in Shares)     145,015        
Net loss (1,151,489) (1,151,489)
Balance at Jun. 30, 2026 $ 148 117,999,522 (111,616,998) (72,981) 6,309,691
Balance (in Shares) at Jun. 30, 2026 17.488 1,499,838        
Balance at Mar. 31, 2026 $ 122 113,563,705 (111,776,942) 1,786,885
Balance (in Shares) at Mar. 31, 2026 17.488   1,240,751        
Common stock issued for cash $ 2 93,934 93,936
Common stock issued for cash (in Shares)     17,900        
Common stock issued for cash - private fundraising $ 6 158,007   158,013
Common stock issued for cash - private fundraising (in Shares)     66,846        
Fair value allocated to warrants during fundraising 2,432,783 2,432,783
Fair value allocated to prefunded warrants during fundraising 1,209,206 1,209,206
Fair value of vested stock options 384 384
Fair value of vested restricted stock awards $ 3 70,585   70,588
Fair value of vested restricted stock awards (in Shares)     29,326        
Fair value of vested restricted stock units $ 15 470,918 (72,981) 397,952
Fair value of vested restricted stock units (in Shares)     145,015        
Net loss 159,944 159,944
Balance at Jun. 30, 2026 $ 148 $ 117,999,522 $ (111,616,998) $ (72,981) $ 6,309,691
Balance (in Shares) at Jun. 30, 2026 17.488 1,499,838